MYELOID SARCOMA – RARE DIFFERENTIAL OF A SUSPECTED LYMPHOMA
Abstract
INTRODUCTION:
Myeloid sarcoma is dened as inltration of tissues and organs other
than bone marrow by precursor myeloid series cells. They are rare
entities and usually mimic a non Hodgkin lymphoma by presenting as
tumors composed of diffusely inltrating round cells and/or with
lymph node enlargement. The bone marrow examination has either not
been done or deferred and is performed once the histopathological
result proposes the diagnosis.
Full Text:
PDFReferences
Pileri SA1, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M, Piccaluga PP,
Agostinelli C, Asioli S, Novero D, Bisceglia M, Ponzoni M, Gentile A, Rinaldi P, Franco
V, Vincelli D, Pileri A Jr, Gasbarra R, Falini B, Zinzani PL, Baccarani M. Myeloid
sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients.
Leukemia. 2007 Feb;21(2):340-50. Epub 2006 Dec 14.
Alexiev BA, Wang W, Ning Y, et al. Myeloid sarcomas: a histologic,
immunohistochemical, and cytogenetic study. Diagn Pathol. 2007;2:42. Published 2007
Oct 31.
Jane Zhou, Diana Bell, and L. Jeffrey Medeiros (2013) Myeloid Sarcoma of the Head
and Neck Region. Archives of Pathology & Laboratory Medicine: November 2013, Vol.
, No. 11, pp. 1560-1568.
Campidelli C, Agostinelli C, Stitson R, Pileri SA. Myeloid sarcoma: extramedullary
manifestation of myeloid disorders. Am J Clin Pathol. 2009;132(3):426–437
Chang CC, Eshoa C, Kampalath B, Shidham VB, Perkins S. Immunophenotypic Prole
of Myeloid Cells in Granulocytic Sarcoma by Immunohistochemistry Correlation with
Blast Differentiation in Bone Marrow. Am J Clin Pathol 2000;114:807-811
Maryam Movassaghian, Andrew M. Brunner, Traci M. Blonquist, Hossein Sadrzadeh,
Ashmeet Bhatia, Ashley M. Perry, Eyal C. Attar, Philip C. Amrein, Karen K. Ballen,
Donna S. Neuberg & Amir T. Fathi (2015) Presentation and outcomes among patients
with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database
analysis, Leukemia & Lymphoma, 56:6, 1698-1703.
Mandelker D, Dal Cin P, Jacene HA, Armand P, Stone RM, Lindeman NI. Refractory
myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high
throughput somatic sequencing. Exp Hematol Oncol. 2015;4:30.
Refbacks
- There are currently no refbacks.